… In our continuing blog series, we talk to some of our longest-serving staffers, those in our … first joined MJFF. In this third installment, Senior Vice President of Research Programs Mark Frasier, PhD , talks to … started here? MF: A lot! Marriage, two children, a house. Becoming domesticated. KV: What's the most important advice …

… “Team Human Powered Potential’s” open-ocean row, completed on July 19, has raised $41 million for The Michael J. Fox Foundation’s strategic research agenda toward better treatments and a cure for Parkinson’s disease … of Team Fox members around the world. For more information, visit us at www.michaeljfox.org , Facebook , Twitter and …

… Background:  Homozygous and compound heterozygous variants in glucocerebrosidase (GBA) can cause Gaucher disease (GD), whereas heterozygous variants increase the risk of … if these are altered in GBA carriers with PD. Objectives:  To determine whether plasma cytokines and immune biomarkers …

… exceptional contributions to Parkinson's research and are committed to mentoring the next generation of Parkinson's … the Illinois Institute of Technology (IIT) in Chicago, where he also played a key role in expanding the biomedical … of Team Fox members around the world. For more information, visit us at  michaeljfox.org , on  Facebook  or  Twitter . …

… sat down with Michael J. Fox at NBC Studios just before the premiere of his new show, which aired last night. In this video exclusive for our community, he shared what it means to him to return to primetime television and what the …

… are associated with Parkinson's disease (PD), and laboratory studies have linked c-Abl to cellular pathways believed … PD. Nilotinib has also shown protective effects in PD preclinical models. Additionally, a small Phase I trial … and impact on PD. The current grant supports a planning committee of leading PD clinicians and researchers to design …